PTC THERAPEUTICS, INC. Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PTC THERAPEUTICS, INC. for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 72.52 | 1,670 | 121,108 | 9,511 | 11.2 K to 9.5 K (-14.94 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 71.12 | 1,500 | 106,680 | 11,181 | 12.7 K to 11.2 K (-11.83 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 70.41 | 5,200 | 366,132 | 12,681 | 17.9 K to 12.7 K (-29.08 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 69.36 | 12,000 | 832,320 | 17,881 | 29.9 K to 17.9 K (-40.16 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 69.77 | 142 | 9,907 | 11,093 | 11.2 K to 11.1 K (-1.26 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 68.72 | 7,547 | 518,630 | 11,235 | 18.8 K to 11.2 K (-40.18 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 67.77 | 13,453 | 911,710 | 18,782 | 32.2 K to 18.8 K (-41.73 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 70.57 | 1,900 | 134,083 | 0 | 1.9 K to 0 (-100.00 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 69.79 | 6,575 | 458,869 | 1,900 | 8.5 K to 1.9 K (-77.58 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 68.96 | 38,725 | 2,670,476 | 8,475 | 47.2 K to 8.5 K (-82.04 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 69.91 | 117 | 8,179 | 8,604 | 8.7 K to 8.6 K (-1.34 %) |
| Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 68.99 | 2,200 | 151,778 | 8,721 | 10.9 K to 8.7 K (-20.14 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 77.53 | 1,716 | 133,041 | 11,848 | 13.6 K to 11.8 K (-12.65 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 76.91 | 5,500 | 423,005 | 13,564 | 19.1 K to 13.6 K (-28.85 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 75.64 | 4,600 | 347,944 | 19,064 | 23.7 K to 19.1 K (-19.44 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 74.75 | 4,800 | 358,800 | 23,664 | 28.5 K to 23.7 K (-16.86 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Kranda Michael L | Director | Sell | S | 73.25 | 800 | 58,600 | 2,242 | 3 K to 2.2 K (-26.30 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Kranda Michael L | Director | Sell | S | 72.61 | 1,700 | 123,437 | 3,042 | 4.7 K to 3 K (-35.85 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 1,250 | 13,563 | 8,125 | |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 9,450 | 102,533 | 96,875 | |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 76.64 | 10,700 | 820,048 | 0 | 10.7 K to 0 (-100.00 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 1,250 | 13,563 | 10,700 | 9.5 K to 10.7 K (+13.23 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 9,450 | 102,533 | 9,450 | 0 to 9.5 K |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Spiegel Robert J. | Chief Medical Offic ... | Sell | S | 75.95 | 2 | 152 | 3,239 | 3.2 K to 3.2 K (-0.06 %) |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Spiegel Robert J. | Chief Medical Offic ... | Sell | S | 75.10 | 1,028 | 77,203 | 3,241 | 4.3 K to 3.2 K (-24.08 %) |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 300 | 3,255 | 106,325 | |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 76.36 | 300 | 22,908 | 0 | 300 to 0 (-100.00 %) |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 300 | 3,255 | 300 | 0 to 300 |
| Mar 11 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 72.27 | 400 | 28,908 | 47,200 | 47.6 K to 47.2 K (-0.84 %) |
| Mar 11 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 71.48 | 3,200 | 228,736 | 47,600 | 50.8 K to 47.6 K (-6.30 %) |
| Mar 11 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 70.67 | 43,601 | 3,081,283 | 50,800 | 94.4 K to 50.8 K (-46.19 %) |
| Mar 11 2015 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP, Research and C ... | Sell | S | 70.71 | 79 | 5,586 | 1,295 | 1.4 K to 1.3 K (-5.75 %) |